Kathryn Robinson

Senior Legal Counsel at Isomorphic Labs

Speaker

Kathryn Robinson is Senior Legal Counsel at Isomorphic Labs, a digital biology company looking to redefine drug discovery with the power of artificial intelligence. She advises on a wide range of commercial and general matters, including drug discovery programs, product, and data licensing. She worked on the two recently announced multi-target research collaborations with Eli Lilly and Company and Novartis. These two partnerships have the potential to be worth nearly $3 billion to Isomorphic Labs, excluding any royalties that may result from future drug sales.

Prior to joining Isomorphic Labs, Kathryn was Senior Legal Counsel at iRhythm Technologies, a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with machine-learning capabilities, and Illumina, whose array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.